Mark D. Plinio's most recent trade in Evelo Biosciences Inc was a trade of 1,250 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on Jan. 31, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evelo Biosciences Inc | Mark D. Plinio | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 31 Jan 2023 | 1,250 | 3,750 (0%) | 0% | 0.9 | 1,100 | Common Stock |
| Evelo Biosciences Inc | Mark D. Plinio | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 31 Jan 2022 | 1,250 | 1,250 (0%) | 0% | 4.0 | 5,004 | Common Stock |
| Evelo Biosciences Inc | Mark D. Plinio | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) |